Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea

Fernando Santamaria-Martos, Ivan Benítez, Cristina Girón, Ferran Barbé, Miguel-Angel Martínez-García, Luis Hernández, Josep M. Montserrat, Eduardo Nagore, Antonio Martorell, Francisco Campos-Rodriguez, Jaime Corral, Valentin Cabriada, Jorge Abad, Olga Mediano, Maria F. Troncoso, Irene Cano-Pumarega, Ana Maria Fortuna Gutierrez, Trinidad Diaz-Cambriles, Maria Somoza-Gonzalez, Isaac Almendros, Ramon Farre, David Gozal, Manuel Sánchez-de-la-Torre

Source: Eur Respir J, 51 (3) 1701885; 10.1183/13993003.01885-2017
Journal Issue: March
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fernando Santamaria-Martos, Ivan Benítez, Cristina Girón, Ferran Barbé, Miguel-Angel Martínez-García, Luis Hernández, Josep M. Montserrat, Eduardo Nagore, Antonio Martorell, Francisco Campos-Rodriguez, Jaime Corral, Valentin Cabriada, Jorge Abad, Olga Mediano, Maria F. Troncoso, Irene Cano-Pumarega, Ana Maria Fortuna Gutierrez, Trinidad Diaz-Cambriles, Maria Somoza-Gonzalez, Isaac Almendros, Ramon Farre, David Gozal, Manuel Sánchez-de-la-Torre. Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea. Eur Respir J, 51 (3) 1701885; 10.1183/13993003.01885-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients
Source: Eur Respir J, 53 (2) 1801298; 10.1183/13993003.01298-2018
Year: 2019



Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea
Source: Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer
Year: 2012

Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
Source: Eur Respir J 2012; 39: 215-217
Year: 2012


Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
Source: Eur Respir J 2011; 39: 215-217
Year: 2012


Association between sleep disordered breathing and aggressiveness markers of malignant cutaneous melanoma
Source: Eur Respir J 2014; 43: 1661-1668
Year: 2014



The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005


Evaluation of sleep related breathing disorders and obstructive sleep apnea in patients with interstitial lung disease
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Prevalence of thyroid disease in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Roles of periostin in patients with severe obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017

The role of angiogenesis in obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018

Bronchial inflammation in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 466s
Year: 2003

Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017



Mechanisms and assessment of vascular damage in obstructive sleep apnoea
Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea”
Year: 2013


Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 362s
Year: 2005

Is sleep related to cancer in murine models of obstructive sleep disorder?
Source: Eur Respir J 2012; 39: 1051
Year: 2012


Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011

Sleep apnoea in interstitial lung disease
Source: Sleep and Breathing Conference 2017
Year: 2017

Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008

Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012